I would have thought endo was a reasonably sized indication. Makes one wonder, if not endo, then what else (besides sarcoma)will they do with their investment in Rida, besides use it to position to buyout ARIA?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.